Navigation Links
OphthaliX Reports First Quarter 2012 Financial Results
Date:5/15/2012

SALT LAKE CITY, May 15, 2012 /PRNewswire/ -- OphthaliX (OTCBB: OPLI) today reported its financial and operating results for the quarter ended March 31, 2012. OphthaliX is an advanced clinical-stage biopharmaceutical company focused on developing therapeutic products for the treatment of ophthalmic disorders.  Our drug, CF101 (known generically as IB-MECA), is being developed to treat three ophthalmic indications: dry eye syndrome; glaucoma and uveitis. We are currently: (i) conducting a Phase III trial with respect to the development of CF101 for dry eye syndrome, under an Investigational New Drug, or IND, application with the United States Food and Drug Administration, or FDA; (ii) conducting a Phase II trial with respect to the development of CF101 for the treatment of glaucoma; and (iii) preparing for Phase II study of the development of CF101 for uveitis.

Prof. Pnina Fishman, interim CEO and Chairman of OphthaliX commented: "We continue to make good progress on the development of CF101 for the ongoing ophthalmic indications with both the Phase 3 Dry Eye and the Phase 2 Glaucoma studies."

For the period from June 27, 2011 (inception date of Eyefite) to March 31, 2012, we did not generate any revenues from operations.  Expenses during the quarter ended March 31, 2012, were $710,000 with a finance expense of $2,114,000 for a net loss of $2,824,000. Expenses for the period mentioned above consisted of research and development activities of $508,000 and general and administrative expenses of $202,000.  These expenses were mainly due to professional, legal and accounting fees relating to our reporting requirements.  The finance expenses were mainly due to a change in the fair value of derivatives in the amount of $2,116,000.  There were no comparable expenses during the prior year quarter ended March 31, 2011. As of March 31, 2012 we had $2,467,000 in cash.  We believe that such funds will be suf
'/>"/>

SOURCE OphthaliX Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
2. Spherix Reports Second Quarter Earnings
3. Tapestry Reports Second Quarter 2007 Results
4. Callisto Reports on Second-Quarter 2007 Milestones
5. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
6. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
7. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
8. TAXUS WOMAN Study Reports Positive Clinical Outcomes for the TAXUS(R) Drug-eluting Stent in Women
9. Biopure Reports on Meeting with the FDA
10. Peregrine Reports Data Showing Bavituximabs Potential to Shrink Prostate Tumors
11. NicOx Reports TOPIGEN to Advance TPI-1020 Into Phase 2 for COPD Following Promising Clinical Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... 2013 Sinovac Biotech Ltd. (Nasdaq: SVA ... , today announced that it will release its unaudited ... before market on Tuesday, May 28, 2013.  The Company will ... 8:00 a.m. EDT (May 28, 2013 at 8:00 p.m. China ... an update on recent corporate developments. To access ...
(Date:5/16/2013)... ZURICH , May 17, 2013 ... and Research (A*STAR) and Switzerland,s Cytos ... been dosed in a Phase 1 clinical trial with their ... virus-like particle (VLP) technology. In this first Phase 1 clinical ... and its potential to protect against H1N1 influenza infection will ...
(Date:5/16/2013)... N.J. , May 16, 2013  PTC Therapeutics, ... statement on Form S-1 with the U.S. Securities and ... offering of its common stock. The number of shares ... offering have not been determined. (Logo:  ... Suisse are acting as joint book-running managers for the ...
Breaking Medicine Technology:Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results 2Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results 3A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 2A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 3A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 4A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 5A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 6PTC Therapeutics, Inc. Files Registration Statement for Proposed Initial Public Offering 2
... A new poll finds little support for privatizing ... insurance program for older Americans needs major changes if ... Recently Medicare,s trustees indicated that funding to ... an estimated 45 million Americans 65 and older, could ...
... June 13, 2011 Enox Biopharma, Inc., a leader ... with medical devices, today announced that it has received ... application entitled "Device and Method for Administering Therapeutic Agents" ... Enox acquired this patent from its ...
Cached Medicine Technology:Little Support for GOP Plan to Privatize Medicare: Poll 2Little Support for GOP Plan to Privatize Medicare: Poll 3Little Support for GOP Plan to Privatize Medicare: Poll 4Little Support for GOP Plan to Privatize Medicare: Poll 5Little Support for GOP Plan to Privatize Medicare: Poll 6Little Support for GOP Plan to Privatize Medicare: Poll 7Enox Biopharma, Inc. Will Be Granted a Patent for the Delivery of Therapeutic Agents From Within Medical Devices 2
(Date:5/18/2013)... a few extra cups of coffee each month might ... known as primary sclerosing cholangitis (PSC), a new study ... Minn., found that drinking coffee was associated with a ... to cirrhosis of the liver, liver failure and biliary ... relationship. "While rare, PSC has extremely detrimental ...
(Date:5/18/2013)... The use of a smartphone application significantly improves ... research presented today at Digestive Disease Week (DDW). ... of the procedure, includes dietary restrictions and requires ... strict intervals. The better the preparation, the easier ... precancerous polyps in the colon. The study, which ...
(Date:5/18/2013)... Minn. -- Regular consumption of coffee is associated ... (PSC), an autoimmune liver disease, Mayo Clinic research ... Digestive Disease Week 2013 conference in Orlando, Fla. ... the bile ducts that results in inflammation and ... the liver, liver failure and biliary cancer. , ...
(Date:5/18/2013)... (PRWEB) May 18, 2013 Assisted ... it comes to safety and comfort of their ... and provides clients with an effective and cost-efficient ... This is an integrated, turnkey communications solution that ... while allowing residents independence and privacy. , ...
(Date:5/18/2013)... City, Utah (PRWEB) May 18, 2013 ... information on insurance agents’ role in Marketplaces ... alternatives to traditional employer sponsored health benefits, is ... contribution and health reimbursement arrangements . ... of Health and Human Services (HHS) recently released ...
Breaking Medicine News(10 mins):Health News:Study Links Coffee to Lower Risk for Rare Liver Disease 2Health News:New smartphone application improves colonoscopy preparation 2Health News:VisionLink Nurse Call System's New Features Serve the Unique Needs of Retirement Communities 2Health News:VisionLink Nurse Call System's New Features Serve the Unique Needs of Retirement Communities 3Health News:Zane Benefits Publishes New Information on Insurance Agents’ Role in Marketplaces 2Health News:Zane Benefits Publishes New Information on Insurance Agents’ Role in Marketplaces 3Health News:Zane Benefits Publishes New Information on Insurance Agents’ Role in Marketplaces 4
... Association (APHA) today released its annual congressional record,which measures ... to public health., APHA,s report was compiled by ... votes during the first session of the 110th,Congress in ... senators voted in support of APHA,s,position on all eight ...
... Texas, (Feb. 1, 2008) - Amgen (NASDAQ: AMGN) and ... announced findings from a retrospective analysis, which demonstrated that ... in patients with moderate to severe plaque psoriasis following ... levels was 10 times greater in the ENBREL treated ...
... Concerns Raised Over DM&E,s Continued Pursuit of Powder River Expansion ... Despite CP,s ... today,asked the U.S. Surface Transportation Board (STB) to require mitigation ... Pacific,s pending,acquisition of the Dakota, Minnesota & Eastern Railroad (DM&E). ...
... SPRING, Md., Feb. 1 The Clinton,Campaign today ... The ANA represents the interests of the nation,s ... do without high quality health care, and this,country ... reform a,priority," said ANA President Rebecca M. Patton, ...
... offered to encourage healthy hearts, GLEN BURNIE, Md., ... Washington Medical Center has the key,to a healthier heart: ... medical center will host the fourth annual Day of ... a.m. to 3 p.m. at the Severna Park,Community Center ...
... WASHINGTON, Feb. 1 The U.S. Department of,Labor,s ... new National Emphasis Program (NEP) to target worksites ... (http://www.osha.gov/ )., "Exposure to silica threatens nearly ... Labor for OSHA Edwin G. Foulke, Jr.,"Under this ...
Cached Medicine News:Health News:APHA Scores Members of Congress on Public Health Voting Record 2Health News:New findings show Enbrel significantly reduced levels of C-reactive protein 2Health News:New findings show Enbrel significantly reduced levels of C-reactive protein 3Health News:New findings show Enbrel significantly reduced levels of C-reactive protein 4Health News:New findings show Enbrel significantly reduced levels of C-reactive protein 5Health News:Mayo Clinic Seeks Mitigation for Rochester as Condition of Canadian Pacific - DM&E Railroad Merger 2Health News:Mayo Clinic Seeks Mitigation for Rochester as Condition of Canadian Pacific - DM&E Railroad Merger 3Health News:Mayo Clinic Seeks Mitigation for Rochester as Condition of Canadian Pacific - DM&E Railroad Merger 4Health News:The American Nurses Association Endorses Senator Hillary Rodham Clinton (D-NY) 2Health News:Baltimore Washington Medical Center Hosts Day of Dance for Health 2Health News:OSHA Establishes a New National Emphasis Program on Silica 2
... System is a fully automated, upgradable platform ... blood parameters in addition to comprehensive on-board ... basic blood gas model to be quickly ... and CO-oximetry in a single unit. This ...
Microcomputer controlled, preparative ultracentrifuge, with CFC-free refrigeration system. Available either internally cooled or with external water cooling. Quikset user interface, Softspin automati...
... SE Micro-ultra centrifuge continues to raise the ... now with 1,048,000 x g performance and ... DiscoveryTMM150SE processes sample sizes from 0.2 ml ... footprint, brushless direct drive, very quiet operation, ...
... environmental safety are the hallmarks ... Ultracentrifuge from Beckman Coulter. With ... technology, the LE-80 K is ... advanced capability for your laboratory ...
Medicine Products: